X-linked Retinitis Pigmentosa
📧 Sign up to get email alerts when something new happens for X-linked Retinitis Pigmentosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene [Phase 3]
Phase 3 follow-up trial update for a gene therapy targeting X-linked retinitis pigmentosa caused by RPGR variants; study status is active bu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) [Phase 2]
This clinical trial update describes a Phase 2 follow-on study evaluating a second-eye treatment in participants with X-linked retinitis pig…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa [Phase 3]
This clinical trial update outlines long-term safety and efficacy follow-up for BIIB111 in choroideremia and BIIB112 for X-linked retinitis …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: InsightRP2 Registry
InsightRP2 Registry is a clinical trial registry monitoring RP2-associated retinitis pigmentosa and X-linked retinitis pigmentosa, currently…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) [Phase 2]
Phase 2 study comparing two doses of AGTC-501 in male participants with X-linked retinitis pigmentosa caused by RPGR mutations; enrollment i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE) [Phase 2]
This clinical trial update describes a Phase 2 study (SKYLINE) evaluating two doses of AGTC-501 in male participants with X-linked retinitis…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa [Phase 1, Phase 2]
This clinical trial update describes an investigational RPGR gene therapy for X-linked retinitis pigmentosa, currently in Phase 1/2 and recr…
-
CLINICAL_TRIALS research · 2015-03-25Clinical Trial Update: Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa [NA]
This is a completed clinical trial studying Docosahexaenoic acid (DHA) supplementation in patients with X-linked retinitis pigmentosa. The s…